Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Biopolymers ; 99(8): 497-507, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23712486

ABSTRACT

Synthetic N-methyl imidazole and N-pyrrole containing polyamides (PAs) that can form "stacked" dimers can be programmed to target and bind to specific DNA sequences and control gene expression. To accomplish this goal, the development of PAs with lower molecular mass which allows for the molecules to rapidly penetrate cells and localize in the nucleus, along with increased water solubility, while maintaining DNA binding sequence specificity and high binding affinity is key. To meet these challenges, six novel f-ImPy*Im PA derivatives that contain different orthogonally positioned moieties were designed to target 5'-ACGCGT-3'. The synthesis and biophysical characterization of six f-ImPy*Im were determined by CD, ΔTM, DNase I footprinting, SPR, and ITC studies, and were compared with those of their parent compound, f-ImPyIm. The results gave evidence for the minor groove binding and selectivity of PAs 1 and 6 for the cognate sequence 5'-ACGCGT-3', and with strong affinity, Keq = 2.8 × 10(8) M(-1) and Keq = 6.2 × 10(7) M(-1), respectively. The six novel PAs presented in this study demonstrated increased water solubility, while maintaining low molecular mass, sequence specificity, and binding affinity, addressing key issues in therapeutic development.


Subject(s)
Base Sequence , Nylons , Circular Dichroism , DNA/chemistry , Surface Plasmon Resonance
2.
Bioorg Med Chem ; 21(13): 3907-18, 2013 Jul 01.
Article in English | MEDLINE | ID: mdl-23647824

ABSTRACT

Orthogonally positioned diamino/dicationic polyamides (PAs) have good water solubility and enhanced binding affinity, whilst retaining DNA minor groove and sequence specificity compared to their monoamino/monocationic counterparts. The synthesis and DNA binding properties of the following diamino PAs: f-IPI (3a), f-IPP (4), f-PIP (5), and f-PPP (6) are described. P denotes the site where a 1-propylamino group is attached to the N1-position of the heterocycle. Binding of the diamino PAs to DNA was assessed by DNase I footprinting, thermal denaturation, circular dichroism titration, biosensor surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC) studies. According to SPR studies, f-IPI (3a) bound more strongly (K(eq)=2.4×10(8) M(-1)) and with comparable sequence selectivity to its cognate sequence 5'-ACGCGT-3' when compared to its monoamino analog f-IPI (1). The binding of f-IPI (3a) to 5'-ACGCGT-3' via the stacked dimer motif was balanced between enthalpy and entropy, and that was quite different from the enthalpy-driven binding of its monoamino parent f-IPI (1). f-IPP (4) also bound more strongly to its cognate sequence 5'-ATGCAT-3' (K(eq)=7.4×10(6) M(-1)) via the side-by-side stacked motif than its monoamino analog f-IPP (2a). Although f-PPP (6) bound via a 1:1 motif, it bound strongly to its cognate sequence 5'-AAATTT-3' (K(eq)=4.8×10(7) M(-1)), 15-times higher than the binding of its monoamino analog f-PPP (2c), albeit f-PPP bound via the stacked motif. Finally, f-PIP (5) bound to its target sequence 5'-ATCGAT-3' as a stacked dimer and it has the lowest affinity among the diamino PAs tested (Keq <1×10(5) M(-1)). This was about two times lower in affinity than the binding of its monoamino analog f-PIP (2b). The results further demonstrated that the 'core rules' of DNA recognition by monoamino PAs also apply to their diamino analogs. Specifically, PAs that contain a stacked IP core structure bind most strongly (highest binding constants) to their cognate GC doublet, followed by the binding of PAs with a stacked PP structure to two degenerate AT base pairs, and finally the binding of PAs with a PI core to their cognate CG doublet.


Subject(s)
DNA/metabolism , Imidazoles/chemistry , Imidazoles/pharmacology , Nylons/chemistry , Nylons/pharmacology , Base Sequence , Binding Sites , Circular Dichroism , DNA/chemistry , DNA Footprinting , Drug Design , Formamides/chemistry , Formamides/pharmacology , Nucleic Acid Conformation , Pyrroles/chemistry , Pyrroles/pharmacology , Surface Plasmon Resonance , Thermodynamics
3.
Bioorg Med Chem Lett ; 23(6): 1699-702, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23395654

ABSTRACT

Hx-amides are fluorescent hybrids of imidazole (I)- and pyrrole (P)-containing polyamides and Hoechst 33258, and they bind in the minor groove of specific DNA sequences. Synthesis and DNA binding studies of HxII (5) complete our studies on the first set of Hx-amides: Hx-I/P-I/P. HxPP (2), HxIP (3) and HxPI (4) were reported earlier. Results from DNase I footprinting, biosensor-SPR, CD and ΔTM studies showed that Hx-amides interacted with DNA via the anti-parallel and stacked, side-by-side motif. Hx was found to mimic the DNA recognition properties of two consecutive pyrrole units (PP) in polyamides. Accordingly, the stacked Hx/PP pairing binds preferentially to two consecutive AT base pairs, A/T-A/T; Hx/IP prefers C-A/T; Hx/PI prefers A/T-C; and Hx/II prefers C-C. The results also showed that Hx-amides bound their cognate sequence at a higher affinity than their formamido-triamide counterparts.


Subject(s)
Amides/chemistry , Anisoles/chemistry , Benzimidazoles/chemistry , DNA/chemistry , Imidazoles/chemistry , Pyrroles/chemistry , Base Pairing , Circular Dichroism , DNA/metabolism , Fluorescent Dyes/chemistry , Nucleic Acid Conformation
4.
Bioorg Med Chem ; 20(2): 693-701, 2012 Jan 15.
Article in English | MEDLINE | ID: mdl-22222156

ABSTRACT

Pyrrole- and imidazole-containing polyamides are widely investigated as DNA sequence selective binding agents that have potential use as gene control agents. The key challenges that must be overcome to realize this goal is the development of polyamides with low molar mass so the molecules can readily diffuse into cells and concentrate in the nucleus. In addition, the molecules must have appreciable water solubility, bind DNA sequence specifically, and with high affinity. It is on this basis that the orthogonally positioned diamino/dicationic polyamide Ph-ImPy*Im 5 was designed to target the sequence 5'-ACGCGT-3'. Py* denotes the pyrrole unit that contains a N-substituted aminopropyl pendant group. The DNA binding properties of diamino polyamide 5 were determined using a number of techniques including CD, ΔT(M), DNase I footprinting, SPR and ITC studies. The effects of the second amino moiety in Py* on DNA binding affinity over its monoamino counterpart Ph-ImPyIm 3 were assessed by conducting DNA binding studies of 3 in parallel with 5. The results confirmed the minor groove binding and selectivity of both polyamides for the cognate sequence 5'-ACGCGT-3'. The diamino/dicationic polyamide 5 showed enhanced binding affinity and higher solubility in aqueous media over its monoamino/monocationic counterpart Ph-ImPyIm 3. The binding constant of 5, determined from SPR studies, was found to be 1.5 × 10(7)M(-1), which is ∼3 times higher than that for its monoamino analog 3 (4.8 × 10(6)M(-1)). The affinity of 5 is now approaching that of the parent compound f-ImPyIm 1 and its diamino equivalent 4. The advantages of the design of diamino polyamide 5 over 1 and 4 are its sequence specificity and the ease of synthesis compared to the N-terminus pyrrole analog 2.


Subject(s)
Benzamides/chemical synthesis , DNA/metabolism , Distamycins/chemistry , Imidazoles/chemical synthesis , Nylons/chemistry , Pyrroles/chemistry , Base Sequence , Benzamides/chemistry , Calorimetry , Circular Dichroism , DNA/chemistry , Deoxyribonuclease I/metabolism , Imidazoles/chemistry , Nylons/chemical synthesis , Surface Plasmon Resonance
5.
Arch Pharm (Weinheim) ; 345(5): 341-8, 2012 May.
Article in English | MEDLINE | ID: mdl-22076705

ABSTRACT

Two divergent series of novel chalcone analogs, one derived from 1-cyclohexylpyrrolidin-2-one and the other derived from 1-benzo[f]chromanone, were designed, synthesized and evaluated for cytotoxicity against two murine cancer cell lines. Two 1-benzo[f]chromanone analogs, 4g and 4j yielded moderate toxicity against both melanoma B16 and lymphoma L1210 cell lines with IC(50) values between the range of 5 and 6 µM. With an IC(50) value of 3.4 µM, compound 4g was also active against human MDA-MB-435 melanoma cells. X-ray structures of the ß-hydroxy ketone product (4a) and the α,ß-unsaturated ketone (4h) were collected, and confirm the syn-configuration between the carbonyl moiety and the ß-vinylic proton in 4h. X-ray structures of two 1-cyclohexylpyrrolidin-2-one derivatives were also obtained, and both showed an E-configuration for the double bond.


Subject(s)
Antineoplastic Agents/chemical synthesis , Chalcones/chemical synthesis , Chromones/chemistry , Cyclohexanes/chemistry , Pyrrolidinones/chemistry , Animals , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Chalcones/chemistry , Chalcones/pharmacology , Drug Design , Humans , Mice , Structure-Activity Relationship , X-Ray Diffraction
6.
Chem Biol Drug Des ; 78(4): 700-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21752198

ABSTRACT

Forty-four novel chalcone-inspired analogs having a 3-aryl-2-propenoyl moiety derived from alicyclic ketones were designed, synthesized, and investigated for cytotoxicity against murine B16 and L1210 cancer cell lines. The analogs belong to four structurally divergent series, three of which (series g, h, and i) contain differently substituted cyclopentanone units and the fourth (series j) contains a 3,3-dimethyl-4-piperidinone moiety. Of these, the analogs in series j showed potential cytotoxic activity against murine B16 (melanoma) and L1210 (lymphoma) cells. The most active compounds 5j, 11j, 15j, and 12h produced IC(50) values from 4.4 to 15 µm against both cell lines. A single-crystal X-ray structure analysis and molecular modeling studies confirmed that these chalcones have an E-geometry about the alkene bond and possess a slightly 'twisted' conformation similar to that of combretastatin A-4. At a concentration of 30 µm, compounds 5j, 11j, and 15j did not cause microtubule depolymerization in cells, suggesting that they have a different mechanism of action.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Chalcones/chemistry , Chalcones/pharmacology , Tubulin Modulators/chemistry , Tubulin Modulators/pharmacology , Animals , Bibenzyls/chemistry , Bibenzyls/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Drug Design , Humans , Ketones/chemistry , Ketones/pharmacology , Mice , Models, Molecular , Neoplasms/drug therapy , Stilbenes/chemistry , Stilbenes/pharmacology , Structure-Activity Relationship
7.
Eur J Med Chem ; 46(7): 3099-104, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21524832

ABSTRACT

Thirteen methylpyrazoline analogs (1a-m) of combretastatin A-4 (CA-4, 2) were synthesized. The trans-geometry of the two substituted phenyl moieties was ascertained by a single crystal X-ray diffraction study of compound 1d. The cytotoxicities of the analogs against the growth of murine B16 melanoma and L1210 lymphoma cells in culture were measured using the MTT assay. One of the derivatives, 1j, which has the same substituents as CA-4 was the most active in the series with IC(50) values of 3.3 µM and 6.8 µM against the growth of L1210 and B16 cells, respectively. The activity of this analog against human cancer cell lines was confirmed in the NCI 60 panel. The other active analogs against L1210 were 1b and 1f, which gave IC(50) values in the 6-8 µM range. Compound 1j caused microtubule depolymerization with an EC(50) value of 4.1 µM. This compound has good water solubility of 372 µM. Molecular modeling studies using DFT showed that compound 1j adopts a "twisted" conformation mimicking CA-4 that is optimal for binding to the colchicine site of tubulin.


Subject(s)
Antineoplastic Agents, Phytogenic/chemical synthesis , Bibenzyls/chemical synthesis , Microtubules/drug effects , Pyrazoles/chemistry , Stilbenes/chemical synthesis , Tubulin Modulators/chemical synthesis , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Bibenzyls/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Crystallography, X-Ray , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , Leukemia L1210/drug therapy , Leukemia L1210/metabolism , Leukemia L1210/pathology , Melanoma, Experimental/chemistry , Melanoma, Experimental/drug therapy , Melanoma, Experimental/pathology , Mice , Microtubules/chemistry , Microtubules/pathology , Molecular Docking Simulation , Stilbenes/pharmacology , Structure-Activity Relationship , Tubulin Modulators/pharmacology
8.
Bioorg Med Chem ; 19(7): 2359-67, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21382720

ABSTRACT

The combretastatins have received significant attention because of their simple chemical structures, excellent antitumor efficacy and novel antivascular mechanisms of action. Herein, we report the synthesis of 20 novel acetyl analogs of CA-4 (1), synthesized from 3,4,5-trimethoxyphenylacetone that comprises the A ring of CA-4 with different aromatic aldehydes as the B ring. Molecular modeling studies indicate that these new compounds possess a 'twisted' conformation similar to CA-4. The new analogs effectively inhibit the growth of human and murine cancer cells. The most potent compounds 6k, 6s and 6t, have IC(50) values in the sub-µM range. Analog 6t has an IC(50) of 182 nM in MDA-MB-435 cells and has advantages over earlier analogs due to its enhanced water solubility (456 µM). This compound initiates microtubule depolymerization with an EC(50) value of 1.8 µM in A-10 cells. In a murine L1210 syngeneic tumor model 6t had antitumor activity and no apparent toxicity.


Subject(s)
Stilbenes/chemical synthesis , Stilbenes/pharmacology , Animals , Crystallography, X-Ray , Female , Humans , Leukemia L1210/drug therapy , Melanoma, Experimental/drug therapy , Mice , Mice, Inbred DBA , Microtubules/drug effects , Microtubules/metabolism , Molecular Conformation , Stilbenes/chemistry , Structure-Activity Relationship
9.
Biochemistry ; 50(15): 3127-36, 2011 Apr 19.
Article in English | MEDLINE | ID: mdl-21388229

ABSTRACT

With the aim of incorporating a recognition element that acts as a fluorescent probe upon binding to DNA, three novel pyrrole (P) and imidazole (I)-containing polyamides were synthesized. The compounds contain a p-anisylbenzimidazolecarboxamido (Hx) moiety attached to a PP, IP, or PI unit, giving compounds HxPP (2), HxIP (3), and HxPI (4), respectively. These fluorescent hybrids were tested against their complementary nonfluorescent, non-formamido tetraamide counterparts, namely, PPPP (5), PPIP (6), and PPPI (7) (cognate sequences 5'-AAATTT-3', 5'-ATCGAT-3', and 5'-ACATGT-3', respectively). The binding affinities for both series of polyamides for their cognate and noncognate sequences were ascertained by surface plasmon resonance (SPR) studies, which revealed that the Hx-containing polyamides gave binding constants in the 10(6) M(-1) range while little binding was observed for the noncognates. The binding data were further compared to the corresponding and previously reported formamido-triamides f-PPP (8), f-PIP (9), and f-PPI (10). DNase I footprinting studies provided additional evidence that the Hx moiety behaved similarly to two consecutive pyrroles (PP found in 5-7), which also behaved like a formamido-pyrrole (f-P) unit found in distamycin and many formamido-triamides, including 8-10. The biophysical characterization of polyamides 2-7 on their binding to the abovementioned DNA sequences was determined using thermal melts (ΔT(M)), circular dichroism (CD), and isothermal titration calorimetry (ITC) studies. Density functional calculations (B3LYP) provided a theoretical framework that explains the similarity between PP and Hx on the basis of molecular electrostatic surfaces and dipole moments. Furthermore, emission studies on polyamides 2 and 3 showed that upon excitation at 322 nm binding to their respective cognate sequences resulted in an increase in fluorescence at 370 nm. These low molecular weight polyamides show promise for use as probes for monitoring DNA recognition processes in cells.


Subject(s)
DNA/metabolism , Drug Design , Imidazoles/chemistry , Nucleic Acid Conformation , Nylons/chemistry , Nylons/metabolism , Pyrroles/chemistry , Base Sequence , Calorimetry , Circular Dichroism , DNA/chemistry , DNA/genetics , Deoxyribonuclease I/metabolism , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/chemistry , Fluorescent Dyes/metabolism , Micrococcal Nuclease/metabolism , Models, Molecular , Nylons/chemical synthesis , Spectrometry, Fluorescence , Substrate Specificity , Surface Plasmon Resonance
10.
Bioorg Med Chem Lett ; 21(7): 2087-91, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21345671

ABSTRACT

Thirteen hydroxyethyl- analogs of combretastatin A-4 (CA-4) that contain the 1-(1'-hydroxyethyl)-1-(3",4",5"-trimethoxyphenyl)-2-(substituted phenyl)ethene framework were synthesized. Molecular modeling studies at the DFT level showed that compound 3j adopts a 'twisted' conformation mimicking CA-4. The cytotoxicity of the novel compounds against the growth of murine B16 melanoma and L1210 lymphoma cells in culture was measured using an MTT assay. Three analogs 3f, 3h, and 3j were active. Of these, 3j, which has the same substituents as CA-4 and IC(50) values of 16.1 and 4.1 µM against B16 and L1210 cells, respectively, was selected for further biological evaluation. The activity of 3j was verified by the NCI 60 cell line screen. Compound 3j causes microtubule depolymerization in A-10 cells with an EC(50) of 21.2 µM. Analog 3j, which has excellent water solubility of 479 µM, had antitumor activity in a syngeneic L1210 murine model.


Subject(s)
Stilbenes/chemistry , Stilbenes/chemical synthesis , Animals , Cell Line, Tumor , Humans , Inhibitory Concentration 50 , Mice , Models, Molecular , Solubility , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...